Vibecotamab, CAS 2138442-13-2

Product Description: Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]FarhadRavandiMBBS, et al. Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study. Blood, Volume 136, Supplement 1, 5 November 2020, Pages 4-5

CAS Number: 2138442-13-2

Molecular Weight: N/A

Compound Purity: 99.34

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD3

• Artikelnummer: MEXHY-P99521-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99521-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated